MedBright AI Investments Inc. announced the release of its new investment presentation, which focuses on MedMatrix, an industry leading AI-powered data analytics platform, developed and operated by Healthcare Accretion AI. As previously announced on August 30, 2023, Healthcare Accretion AI, formerly named Healthcare Accretion Group, is one of MedBright's most significant investments. The presentationlines how MedMatrix is set to drastically improve healthcare operations by empowering doctors and operators to enhance clinic revenue, reduce physician burnout, and improve patient satisfaction.

MedMatrix harnesses the power of artificial intelligence to evaluate and analyze key aspects of healthcare facilities, including patient needs and resource matching, revenue cycle management, patient demographics, facility geography, and competition. Through its advanced AI and data analytics capabilities, MedMatrix works alongside healthcare professionals to optimize each of these critical areas, resulting in more efficient clinic operations and improved patient outcomes. Key Features of MedMatrix: Advanced Analytics: MedMatrix employs machine-learning algorithms to provide in-depth insights into clinic performance, enabling doctors and operators to make informed decisions.

Real-Time Scheduler Improvements: MedMatrix's real-time scheduler enhancements not only increase clinic revenue but also enhance patient satisfaction and physician experience. By optimizing appointment scheduling, it minimizes wait times and reduces physician burnout. Personalized Care: With its ability to match patient needs with enhanced pricing and quality of care, MedMatrix helps healthcare facilities provide personalized and high-quality services.

The unveiling of MedMatrix and the investment presentation coincides with MedBright AI's commitment to the healthcare AI sector and its dedication to identifying high-growth opportunities in the United States. The investment presentation provides valuable insights into MedBright AI Investments Inc.'s evolving investment strategy and its role as a key player in the healthcare AI industry.